SynBiotic SE (SBX.DE)
SynBiotic SE operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Munich, NW, DE. The stock last traded at $1.05, up 0.00% on the session, giving a market capitalisation of $5.0M. Its beta of 0.68 implies it has historically moved less than the broad market.
SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and readily available health and wellness items. Its primary strategic pillars include the laboratory synthesis of cannabinoids, advanced drug discovery, the formulation of dietary aids, and the creation of cosmetic solutions. Formerly operating as Ledgertech SE, the company is headquartered in Munich, Germany.
SynBiotic SE is most often compared with the following Healthcare names: